Company / Total Assets
Perspective Therapeutics, Inc. Total Assets History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$58.1M
FY2022
5-year range
$7.5M / $70.4M
FY2018-FY2022
Trend
-17.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 10 years, ranging from $7M in FY2013 to $70M in FY2021.
Based on SEC 10-K filings.
$58M in FY2022 with a 5-year CAGR of +36.5%.
Improved from $9M to $58M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +83.4%
- 5-Year CAGR
- +36.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +36.5%, indicating consistent growth.
- In FY2022, total assets decreased 17.5% year-over-year.
- Peak total assets was recorded in FY2021.
- Lowest total assets in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $58.1M | -17.5% |
| FY2021 | $70.4M | +709.5% |
| FY2020 | $8.7M | -7.7% |
| FY2019 | $9.4M | +26.4% |
| FY2018 | $7.5M | -39.2% |
| FY2017 | $12.3M | -32.2% |
| FY2016 | $18.1M | -21.3% |
| FY2015 | $23.0M | -13.4% |
| FY2014 | $26.5M | +276.3% |
| FY2013 | $7.1M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026